What is Intuitive Surgical?
Robotic-assisted surgery company with $10.1B of 2025 revenue and enterprise healthcare scale.
- Category
- Robotic-assisted surgery
- Headquarters
- Sunnyvale, CA
- Founded
- 1995
- Employees
- 18,000+
- Total funding
- Public company; no VC funding
- Status
- Nasdaq: ISRG; ~$200B market cap
What is Intuitive Surgical?
Intuitive Surgical is a public robotic-assisted surgery company headquartered in Sunnyvale, CA. It reported $10.1B of 2025 revenue and operates at global enterprise scale.
Intuitive Surgical operates in robotic-assisted surgery with a portfolio spanning Systems, instruments and accessories, and service revenue. The company reported $10.1B of 2025 revenue, employs about 18,000+, and trades as Nasdaq: ISRG. Its customer base is large, regulated, and relationship-driven, with purchasing decisions shaped by clinical outcomes, compliance, reimbursement, operating leverage, and long-term supply reliability.
The company's scale comes from durable demand in healthcare, recurring consumables or services, installed bases, payer or provider relationships, and disciplined capital allocation. Unlike early-stage software companies, Intuitive Surgical is evaluated through revenue growth, margins, cash flow, reimbursement exposure, procedure or prescription volume, quality, and regulatory execution.
For sellers, Intuitive Surgical is not a single buying center. The practical map includes procurement, finance, clinical, IT, security, compliance, operations, supply chain, commercial teams, and business-unit executives. Strong pitches connect directly to patient outcomes, cost-to-serve, risk reduction, revenue capture, uptime, or measurable productivity.
What does Intuitive Surgical offer?
Intuitive Surgical offers healthcare products and services across Systems, instruments and accessories, and service revenue.
- da Vinci surgical systems· Robotics
- da Vinci 5· Robotics
- Instruments and accessories· Recurring products
- Ion endoluminal system· Robotics
- Service contracts· Services
- Simulation and training· Education
- Digital ecosystem· Software
How does Intuitive Surgical make money?
Intuitive sells and leases robotic systems, then generates recurring instruments, accessories, and service revenue as procedure volume grows.
Intuitive sells and leases robotic systems, then generates recurring instruments, accessories, and service revenue as procedure volume grows. In 2025, that model produced $10.1B of revenue, showing the scale of the installed base, service footprint, payer/provider contracts, or distribution volume behind the business.
Pricing is capital-system-, lease-, procedure-, instrument-, accessory-, and service-contract driven; hospitals evaluate da Vinci and Ion through capital committees, clinical utilization, service economics, and per-procedure ROI. That makes the relevant "pricing tier" for sellers an enterprise contracting motion: account segmentation, compliance review, value analysis, legal terms, security review, reimbursement impact, and multi-year renewal economics.
Growth is driven by a mix of market expansion, procedure or prescription volume, product launches, acquisitions, geographic reach, contract renewals, operational efficiency, and technology adoption. Vendors should expect rigorous procurement, documented ROI, data-security requirements, and evidence that the product can work inside regulated healthcare operations.
Who leads Intuitive Surgical?
Intuitive Surgical is led by David J. Rosa, with finance, operations, clinical, technology, and business-unit leaders shaping major enterprise decisions.
- David J. RosaChief Executive Officer and Board MemberCEO effective July 2025Longtime Intuitive executive promoted after leading strategy and growth.
- Gary S. GuthartExecutive ChairCEO 2010-2025; Executive Chair since 2025Longtime leader supporting the CEO transition and board strategy.
- Jamie E. SamathChief Financial Officer and Enterprise Technology LeaderCFO since 2020Finance and enterprise technology executive.
- Jaime WongSenior Vice President and Chief Medical OfficerSenior executive leadershipClinical leader for safety, medical affairs, and evidence.
How do you contact Intuitive Surgical's leadership?
Intuitive Surgical publishes investor-relations, media, supplier, customer, and compliance channels, but it does not publish verified personal executive emails for the listed leaders. Use the public investor-relations route (investor.relations@intusurg.com) or official contact forms rather than guessed personal addresses.
investor.relations@intusurg.com is a public investor/contact route; personal executive email format not verified- Jamie E. SamathChief Financial Officer and Enterprise Technology Leaderinvestor.relations@intusurg.com
How much funding has Intuitive Surgical raised?
Intuitive Surgical is a mature public company, not a venture-backed startup. It trades as Nasdaq: ISRG, had an approximate ~$200B market capitalization in June 2026, and funds growth through operating cash flow, debt markets, public equity access, and acquisition capacity.
Intuitive Surgical's capital history is a public-company story rather than a disclosed venture-round history. The relevant milestones are founding in 1995, public-market access, acquisitions, debt capacity, dividends or buybacks where applicable, and reinvestment in regulated healthcare capabilities.
The company reported $10.1B of 2025 revenue and operates with the financing tools expected of a large public healthcare company. Capital is directed toward product development, clinical evidence, facilities, inventory, technology, acquisitions, compliance, reimbursement capabilities, and shareholder returns depending on the business model.
Seller signal: Intuitive Surgical has meaningful buying power, but budget access is tied to risk, ROI, compliance, and executive sponsorship. Vendors should map proposals to cost reduction, growth, care quality, automation, supply resilience, cybersecurity, data quality, or measurable operating improvement.
How did Intuitive Surgical get here?
Intuitive Surgical grew through founding, public-market scale, product expansion, acquisitions, and healthcare-market execution.
- 1995Company foundedIntuitive begins developing robotic-assisted surgical systems.
- 2000IPO and da Vinci clearanceThe company lists publicly and da Vinci gains FDA clearance.
- 2019Ion system clearedIntuitive enters robotic-assisted bronchoscopy.
- 2024da Vinci 5 clearedThe next-generation da Vinci platform reaches the U.S. market.
- 2025CEO transitionDave Rosa becomes CEO and Gary Guthart becomes executive chair.
- 2025$10.1B revenueIntuitive reports 21% revenue growth and a larger installed base.
Who are Intuitive Surgical's competitors?
Intuitive Surgical competes with companies that overlap in customers, budgets, clinical categories, distribution channels, or healthcare services.
- MedtronicDevelops Hugo and broader surgical technology competing for robotic surgery budgets.
- Johnson & Johnson MedTechDevelops surgical robotics and has broad surgical-device relationships.
- StrykerCompetes in surgical robotics through Mako in orthopaedics.
- Zimmer BiometOrthopaedic robotics competitor with ROSA.
- CMR SurgicalSoft-tissue surgical robotics competitor with Versius.
Intuitive Surgical — frequently asked questions
